• No results found

ANALYTICAL METHOD VALIDATION AND QUANTIFICATION OF AZILSARTAN KAMEDOXOMIL DRUG SUBSTANCE AND ITS RELATED SUBSTANCES BY USING REVERSE PHASE LIQUID CHROMATOGRAPHIC METHOD

N/A
N/A
Protected

Academic year: 2020

Share "ANALYTICAL METHOD VALIDATION AND QUANTIFICATION OF AZILSARTAN KAMEDOXOMIL DRUG SUBSTANCE AND ITS RELATED SUBSTANCES BY USING REVERSE PHASE LIQUID CHROMATOGRAPHIC METHOD"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Figure

Fig. 1: Chemical structure of Azilsartan kamedoxomil.
Fig. 2: A Typical HPLC chromatogram of (a) System suitability, (b) Diluent and (c)
Table 1: Specificity Data And Stress Conditions Of Azilsartan Medoxomil And Its Impurities
Table 2: Summary Of Linearity / Lod-Loq Experiments. Response Linearity Correlation LOD
+2

References

Related documents

To verify the results of quantitative determination of propolis tincture, naftifine hydrochloride, chlorquinaldol, salicylic acid, and chlorhexidine digluconate in

The system suitability was established in terms of resolution between Hydroxy Aliskiren-1 and Aliskiren should not be less than 1.5 and theoretical plates for

extracted low, medium and high quality control samples to mean peak areas of three neat.. reference solutions

TX 1~AT/TX 2~AT Vol 12, Issue 9, 2019 Online 2455 3891 Print 0974 2441 SIMULTANEOUS QUANTIFICATION OF PENTAZOCINE AND NALOXONE BY STABILITY INDICATING REVERSE PHASE HIGH PERFORMANCE

Vol 9, Issue 1, 2016 ISSN 0974 2441 DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE PHASE HIGH?PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE ESTIMATION OF PIRIBEDIL IN

chromatographic method with experimental design approach for bromfenac. The aim of the present work was, experimental design based development and validation of

The average peak area of the standard (n=6) and of the sample (n=2) solution was obtained from the software and the concentration of the drug in formulation was calculated

VALIDATED REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE AND AMLODIPINE BESYLATE IN NEWLY